Skip to main content
. 2025 Mar 6;14(5):1775. doi: 10.3390/jcm14051775
ACPA Anti-cyclic citrullinated peptide antibodies
ACR American College of Rheumatology
AEs Adverse events
bDMARDs Biological disease-modifying anti-rheumatic drugs
CDAI Clinical disease activity index
CI Confidence interval
CRB Certified review board
CRP C-reactive protein
csDMARDs Conventional synthetic disease-modifying antirheumatic drugs
DAS28 Disease Activity Score—28
ELISA Enzyme-Linked Immuno Sorbent Assay
ESR Erythrocyte sedimentation rate
EULAR European League Against Rheumatism
FAS Full analysis set
GLOESS Global OMERACT-EULAR Synovitis Score
GS Gray scale
HAQ-DI Health Assessment Questionnaire–Disability Index
IL Interleukin
IP Interphalangeal
IQR Interquartile range
JAK Janus kinase
JCR Japan College of Rheumatology
MCP Metacarpophalangeal
MMP-3 Matrix metalloproteinase-3
MSUS Musculoskeletal ultrasound
MTX Methotrexate
OMERACT Outcome Measures in Rheumatology
PD Power Doppler
PIP Proximal interphalangeal
PSL Prednisolone
RA Rheumatoid arthritis
RF Rheumatoid factor
RP Reference product
SDAI Simplified disease activity index
SRM Standardized response mean
TNF Tumor necrosis factor
T2T treat-to-targe
vdH-mTSS Van der Heijde-modified total Sharp score